SpaceX vs Health Care Select Sector SPDR Fund — how do they compare? SpaceX trades at $123.46 (market cap $1.58T), while Health Care Select Sector SPDR Fund trades at $160.31. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, SpaceX nearer its low. Which is the better fit depends on your goals.
| SPCX | XLV | |
|---|---|---|
Market Cap | $1.58T | — |
Sector | Technology | — |
52-Week High | $202.09 | $164.48 |
52-Week Low | $119.85 | $129.01 |
Enterprise Value | $1.59T | — |
Signals from Pluang's Aura AI — not financial advice
SPCX trades at $123.46, down 0.43% amid bearish technical signals despite recent rebound attempts. The company shows strong revenue growth with $18.67B in 2025 but faces significant profitability challenges with a -45% net income margin. Analyst consensus remains strongly bullish with a $237.78 price target, though upcoming August earnings and share unlock events create near-term uncertainty.
While SpaceX maintains strong revenue momentum and AI infrastructure potential, investors face substantial risks from persistent losses, high valuations, and imminent share dilution. The stock's technical weakness contrasts with Wall Street's long-term optimism, creating a high-risk, high-reward scenario dependent on upcoming earnings execution and competitive positioning.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →